Treatment with the tyrosine kinase inhibitors Gleevec (imatinib) or PTK787/ZK 222584, siRNA-mediated knock down of Vascular Endothelial Growth Factor (VEGF) and/or IL6[16,17] potently inhibited tumour angiogenesis and growth in this model. This evidence concerns the gene VEGFA and neoplasm.